Now in its 6th year, World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data.

Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40 others will divulge unpublished, never seen before ADC drug research.

Over 3 days, 60 sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC programme.

Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.